The global blood transfusion market size was valued at USD 7.53 billion in 2025 and is projected to grow from USD 7.98 billion in 2026 to USD 12.72 billion by 2034, registering a CAGR of 6% during the forecast period from 2026 to 2034. North America dominated the blood transfusion market with a market share of 38.42% in 2025.
Blood transfusion is a medical procedure in which blood or blood components, such as red blood cells, platelets, or plasma, are transferred into a patient’s bloodstream. Blood transfusions help restore blood volume, improve oxygen delivery, and support normal body functions.
Download a Free Sample To learn more about this report,
AI-Enabled Quality Control in Blood Component Processing
The growing volume of blood components handled by transfusion centers is increasing the value of AI-enabled quality control, with machine learning tools supporting automated monitoring of component quality, process deviations, and storage conditions; recent research has identified AI applications across blood component processing and quality management, including predictive error detection and statistical process control.
Shift Toward Automated Blood Component Processing
Operational pressure to improve consistency and reduce manual handling is shifting blood component processing toward automated systems, where centrifugation, separation, weighing, labeling, and component preparation can be integrated into standardized workflows; automated blood component processing systems can process multiple units with reduced operator intervention, supporting more consistent preparation and traceability.
Increasing Prevalence of Blood Disorders and Expansion of Cancer Treatment Services Drive Market
The rising prevalence of blood disorders increases demand for regular transfusions and blood components, particularly among patients requiring long-term supportive care. Conditions such as thalassemia and sickle cell disease can require repeated red blood cell transfusions to manage anemia and maintain adequate oxygen supply. For example, patients with transfusion-dependent thalassemia may require scheduled blood transfusions throughout their lives. The growing patient population therefore increases recurring demand for screened blood, red blood cells, and other transfusion components.
The expansion of cancer treatment services increases demand for blood components because chemotherapy and hematopoietic stem-cell transplantation can reduce blood cell and platelet levels. Patients with leukemia and other blood cancers may require transfusions to manage anemia or low platelet counts during treatment. For example, platelet and red blood cell transfusions are commonly used to support patients undergoing intensive cancer treatment. Growing oncology capacity therefore increases hospital requirements for reliable blood inventories and supports demand across transfusion services.
Shortage of Blood Donors and Low Voluntary Blood Donation Rates in Some Regions Restrain Market Expansion
An insufficient donor pool can reduce the availability of whole blood and blood components needed for transfusion services. Limited supply can create shortages during periods of high clinical demand and increase pressure on blood collection and inventory management. This constraint can delay transfusion procedures and limit the capacity of healthcare facilities to meet patient requirements.
Low participation in voluntary blood donation can restrict the regular replenishment of blood inventories, particularly in regions with limited donor awareness or established collection infrastructure. Irregular donations can create gaps between blood demand and available supplies and increase dependence on replacement or emergency donations. These supply constraints can limit access to transfusion services and slow market expansion.
Expansion of Blood Plasma-Derived Products and Growth of Point-of-Care Blood Testing Offer Growth Opportunities
Plasma processors and pharmaceutical companies can target demand for albumin, immunoglobulins, and clotting-factor therapies derived from collected plasma. Companies such as CSL Behring and Takeda can expand revenue through plasma-derived product portfolios, processing capacity, and supply partnerships. Higher-value plasma applications can also improve revenue generation from each collected plasma unit.
Hospitals, blood banks, and diagnostic providers can adopt rapid systems for blood typing and compatibility testing near the point of transfusion. Companies such as Abbott and QuidelOrtho can create additional revenue through portable analyzers, testing platforms, and recurring consumable sales. Decentralized testing can also create demand for compact systems across smaller hospitals and transfusion centers.
Increasing Demand for Specialized Blood Components and Complexity of Maintaining Cold-Chain Logistics Hinders Growth
Growing use of cancer treatment, organ transplantation, trauma care, and complex surgeries increases demand for specific components such as platelets and plasma. For example, hematological cancer patients undergoing chemotherapy may require repeated platelet transfusions, placing additional pressure on component inventories and distribution networks.
Blood components require controlled storage and transportation conditions, making reliable temperature management essential across collection, processing, storage, and delivery. For example, WHO identifies inadequate blood-storage and transportation systems as a challenge in low-resource settings, where cold-chain gaps can increase component losses and restrict expansion of transfusion services.
The blood bag and accessory segment accounted for a market share of 24.36% in 2025 due to their essential role in the collection, storage, handling, and transportation of donated blood and blood components. The routine requirement for sterile blood bags and related accessories across blood banks, hospitals, and transfusion centers supports consistent demand for these products.
The pathogen reduction system segment is expected to grow at a CAGR of 6.48%, driven by increasing emphasis on reducing the risk of transfusion-transmitted infections. Growing adoption of technologies that screen or treat donated blood components to reduce pathogen-related risks is supporting demand for pathogen reduction systems. The blood mixer segment is supported by its use in maintaining uniform blood and component mixtures during collection and processing. Its ability to provide controlled and consistent mixing helps improve the accuracy and efficiency of blood collection and component preparation workflows. The blood component separator segment benefits from its role in separating donated blood into components such as red blood cells, plasma, and platelets. Increasing demand for component-based transfusion practices supports the use of separation equipment in blood banks and healthcare facilities.
The apheresis device segment is driven by the increasing use of apheresis procedures to selectively collect specific blood components while returning the remaining components to the donor. Its application in platelet, plasma, and therapeutic apheresis supports demand across specialized blood collection and treatment settings. The consumables and supplies segment is supported by the recurring need for disposable products used throughout blood collection, processing, testing, and transfusion procedures. Regular replacement requirements and the high volume of transfusion activities across healthcare facilities contribute to sustained demand for these products.
Request Customizationto receive a tailored report.
The hospitals segment accounted for a market share of 52.68% in 2025 due to the high volume of blood transfusion procedures performed in hospitals for surgeries, trauma care, cancer treatment, and other medical conditions requiring blood or blood components. The availability of blood storage facilities, transfusion services, and specialized healthcare infrastructure supports sustained demand for blood transfusion products in hospitals.
The ambulatory surgical centers segment is expected to grow at a CAGR of 6.4%, driven by the increasing number of surgical procedures performed in outpatient settings. Growing adoption of minimally invasive and same-day procedures is supporting demand for blood transfusion products where blood management and transfusion support are required. The blood bank segment is supported by its central role in collecting, testing, processing, storing, and distributing donated blood and blood components. The continuous need to maintain adequate blood inventories for hospitals and transfusion centers supports demand for blood collection and processing equipment and supplies.
Speak to an Analystto discuss market opportunities.
The North America Blood Transfusion Market accounted for the largest regional share of 38.42% in 2025, supported by sustained demand for blood and blood components across healthcare facilities, with the U.S. healthcare system requiring approximately 29,000 units of red blood cells, nearly 5,000 units of platelets, and 6,500 units of plasma every day, highlighting the continued need for blood transfusion services in the region.
The United States Blood Transfusion Market is expected to benefit from an aging population and rising transfusion needs, with U.S. demographic projections indicating continued growth in the population aged 65 and older through 2030, while recent national blood-utilization data show that platelet transfusions increased 2.1% between 2021 and 2023, supporting continued demand for blood components. The Canada Blood Transfusion Market is expected to benefit from rising hospital demand, with Canadian Blood Services reporting that demand for blood products has increased as the population grows and ages, while the organization is recruiting 1 million new donors over five years to meet growing future demand for blood and plasma products.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia Pacific Blood Transfusion Market is expected to grow at a CAGR of 6.42% during the forecast period, showcasing the fastest-growing regional market, supported by increasing healthcare access and transfusion needs, with WHO reporting that red-cell product transfusions in Southeast Asia increased by 24% between 2013 and 2018, while demand for safe blood and blood products continues to exceed supply in several countries, indicating continued need for blood-collection and transfusion infrastructure.
The Japan Blood Transfusion Market is expected to benefit from population aging, with Japan’s National Institute of Population and Social Security Research projecting the share of people aged 65 and above to increase from 28.6% in 2020 to 38.7% by 2070, while the total population is projected to decline from 126.15 million to 87 million, increasing the healthcare needs associated with an older population. The China Blood Transfusion Market is expected to benefit from population aging, with China’s National People’s Congress projecting the population aged 60 and above to reach 400 million by 2033 and approximately 487 million by around 2050, accounting for 34.8% of the total population, supporting long-term demand for blood transfusion services.
The South Korea Blood Transfusion Market is expected to benefit from population aging, with South Korea’s National Assembly Budget Office projecting the population aged 65 and above to increase from 10.51 million in 2025 to 17.27 million by 2072, raising its share from 20.3% to 47.7% of the population and increasing healthcare demand. The India Blood Transfusion Market is expected to benefit from population aging, with UNFPA projecting India’s population aged 60 and above to reach around 300 million by 2050, representing approximately 20% of the total population, while the 80-and-above population is projected to increase by 700% between 2000 and 2050, supporting longer-term demand for healthcare and transfusion services.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Ambulance Services Market Size, Share, Growth, Analysis, 2034
North America Clinical Laboratory Tests Market Analysis, Share to 2034
Medical Device Analytical Testing Outsourcing Market Size, 2034
Drug Discovery Market Size, Share, Growth, Analysis, Report, 2034
Cosmetic Dentistry Market Size, Share, Growth, Analysis, 2034
Infection Control Market Size, Share, Growth, Forecast, 2034
We are featured on:
sales@straitsresearch.com